X

8

8

h

S

M

© 2011 Exar Corporation

7/7

Rev. 2.2.0

REVISION HISTORY

Revision

Date

Description

1.0.0

08/05/2010

Initial release of document

1.1.0

09/22/2010

Added evaluation board picture

2.0.0

03/28/2011

Added R13 and R14 to isolate FBx and SBDx

2.1.0

07/29/2011

Modified schematics C1 and C2 to 100nF

2.2.0

08/18/2011

Added default settings information

Corrected schematics for inclusion of R13 and R14

BOARD REVISION HISTORY

Board Revision

Date

Description

146-6686-01

10/29/2010

Initial release of evaluation board

146-6686-02

03/28/2011

Added R13 and R14 to isolate FBx and SBDx

FOR FURTHER ASSISTANCE

Email:

customersupport@exar.com

Exar Technical Documentation:

http://www.exar.com/TechDoc/default.aspx?

48720 Kato Road

Fremont, CA 94538 – USA

Tel.: +1 (510) 668-7000

Fax: +1 (510) 668-7030

www.exar.com

NOTICE

EXAR Corporation reserves the right to make changes to the products contained in this publication in order to improve

design, performance or reliability. EXAR Corporation assumes no responsibility for the use of any circuits described herein,

conveys no license under any patent or other right, and makes no representation that the circuits are free of patent

infringement. Charts and schedules contained here in are only for illustration purposes and may vary depending upon a

user’s specific application. While the information in this publication has been carefully checked; no responsibility, however,

is assumed for inaccuracies.

EXAR Corporation does not recommend the use of any of its products in life support applications where the failure or

malfunction of the product can reasonably be expected to cause failure of the life support system or to significantly affect its

safety or effectiveness. Products are not authorized for use in such applications unless EXAR Corporation receives, in

writing, assurances to its satisfaction that: (a) the risk of injury or damage has been minimized; (b) the user assumes all

such risks; (c) potential liability of EXAR Corporation is adequately protected under the circumstances.

Reproduction, in part or whole, without the prior written consent of EXAR Corporation is prohibited.